STERIS plc logo
STESTERIS plc

Debt to Equity Ratio: 0.29

popular:market cap|pe ratio|revenue|price history|total return

Is the debt to equity ratio high or low?

The debt to equity ratio of 0.29 is 36% below its 5-year average of 0.46, near the low end of its 5-year range (0.29–0.59).

As of Friday, June 26, 2026. 3.26% below its 12-month average of 0.30.

Current Ratio|Quick Ratio|ROE|All Metrics
Debt to Equity

STE Debt to Equity Ratio

0.29

Reported quarterly debt to equity ratio; no daily interpolation.

-50.24% 5Y
STE Debt to Equity Ratio

STE Average Debt to Equity Ratio Chart

STE Debt to Equity Ratio

STE Current vs Average Debt to Equity Ratio Chart

STE Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

0.29

DEBT TO EQUITY RATIO AVG TTM

0.30

DEBT TO EQUITY RATIO AVG 3Y

0.41

DEBT TO EQUITY RATIO AVG 5Y

0.46

DEBT TO EQUITY RATIO AVG 10Y

0.45

DEBT TO EQUITY RATIO AVG 15Y

0.46

DEBT TO EQUITY RATIO AVG 20Y

0.40

CURRENT VS TTM AVG

-3.26%

CURRENT VS 3Y AVG

-29.15%

CURRENT VS 5Y AVG

-36.15%

CURRENT VS 10Y AVG

-35.04%

CURRENT VS 15Y AVG

-36.18%

CURRENT VS 20Y AVG

-28.09%

STE Competitors' Debt to Equity Ratio

NAMEMARKET CAPDEBT TO EQUITY RATIOTTM3Y5Y
STERIS plc (STE)$20.52B0.290.300.410.46
Incyte Corporation (INCY)vs ›$21.48B0.010.010.010.01
Labcorp Holdings Inc. (LH)vs ›$21.83B0.840.870.780.74
Viatris Inc. (VTRS)vs ›$18.71B1.000.890.900.98
BioNTech SE (BNTX)vs ›$22.76B0.010.010.010.04
Quest Diagnostics Incorporated (DGX)vs ›$22.83B0.961.000.920.85
United Therapeutics Corporation (UTHR)vs ›$23.07B0.000.030.090.13
Zimmer Biomet Holdings, Inc. (ZBH)vs ›$17.60B0.590.540.510.54
Moderna, Inc. (MRNA)vs ›$23.71B0.220.150.110.10
Hologic, Inc. (HOLX)vs ›$16.97B0.520.520.550.69

Financial Health

Debt/Equity

0.29

Current Ratio

2.09

Debt to Equity Ratio Formula & Definition

Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Debt to Equity Ratio FAQ

What is the debt to equity ratio for STERIS plc (STE)?
The debt to equity ratio for STE stock is 0.29.
Is STERIS plc's debt to equity ratio high or low?
The debt to equity ratio of 0.29 is 36% below its 5-year average of 0.46, near the low end of its 5-year range (0.29–0.59).
What is the TTM average debt to equity ratio for STERIS plc (STE)?
The TTM average debt to equity ratio for STE stock is 0.30.
What is the 3Y average debt to equity ratio for STERIS plc (STE)?
The 3Y average debt to equity ratio for STE stock is 0.41.
What is the 5Y average debt to equity ratio for STERIS plc (STE)?
The 5Y average debt to equity ratio for STE stock is 0.46.
What is the 10Y average debt to equity ratio for STERIS plc (STE)?
The 10Y average debt to equity ratio for STE stock is 0.45.
What is the 15Y average debt to equity ratio for STERIS plc (STE)?
The 15Y average debt to equity ratio for STE stock is 0.46.
What is the 20Y average debt to equity ratio for STERIS plc (STE)?
The 20Y average debt to equity ratio for STE stock is 0.40.

STE Debt to Equity Ratio History

DATEDEBT TO EQUITY RATIO
2026-03-310.29
2025-12-310.29
2025-09-300.29
2025-06-300.30
2025-03-310.33
2024-12-310.36
2024-09-300.36
2024-06-300.39
2024-03-310.54
2023-12-310.55
2023-09-300.59
2023-06-300.51
2023-03-310.53
2022-12-310.54
2022-09-300.55
2022-06-300.50
2022-03-310.50
2021-12-310.53
2021-09-300.56
2021-06-300.58
2021-03-310.46
2020-12-310.48
2020-09-300.32
2020-06-300.35
2020-03-310.38
2019-12-310.37
2019-09-300.40
2019-06-300.41
2019-03-310.37
2018-12-310.40
2018-09-300.41
2018-06-300.43
2018-03-310.41
2017-12-310.46
2017-09-300.48
2017-06-300.51
2017-03-310.53
2016-12-310.55
2016-09-300.50
2016-06-300.51
2016-03-310.52
2015-12-310.55
2015-09-300.76
2015-06-300.63
2015-03-310.58
2014-12-310.57
2014-09-300.58
2014-06-300.62
2014-03-310.48
2013-12-310.47
2013-09-300.51
2013-06-300.53
2013-03-310.52
2012-12-310.57
2012-09-300.49
2012-06-300.25
2012-03-310.26
2011-12-310.27
2011-09-300.27
2011-06-300.26
2011-03-310.27
2010-12-310.28
2010-09-300.29
2010-06-300.30
2010-03-310.28
2009-12-310.42
2009-09-300.26
2009-06-300.28
2009-03-310.29
2008-12-310.29
2008-09-300.34
2008-06-300.25
2008-03-310.25
2007-12-310.18
2007-09-300.16
2007-06-300.14
2007-03-310.13
2006-12-310.17
2006-09-300.21
2006-06-300.27
2006-03-310.16
2005-12-310.15
2005-09-300.15
2005-06-300.18
2005-03-310.14
2004-12-310.14
2004-09-300.16
2004-06-300.16
2004-03-310.17
2003-12-310.18
2003-09-300.17
2003-06-300.20
2003-03-310.11
2002-12-310.16
2002-09-300.20
2002-06-300.22

Related Metrics

Current RatioQuick RatioROEAll Metrics

About STERIS plc

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

Mentor, OH
17,840 employees
www.steris.com
Healthcare / Medical - Equipment & Services
Sector
Healthcare
Industry
Medical - Equipment & Services
CEO
Daniel A. Carestio
View full financials